Logotype for Imugene Limited

Imugene (IMU) investor relations material

Imugene Collaboration summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Imugene Limited
Collaboration summary27 Nov, 2025

Opening remarks and agenda

  • The session began with a 10-minute presentation followed by a Q&A segment for participants to submit questions via Zoom.

  • Announced a strategic collaboration to evaluate a novel combination therapy for refractory solid tumors.

  • The partnership was jointly released by both companies' CEOs and authorized by their leadership.

Objectives of the partnership

  • The collaboration aims to combine an oncolytic virus platform with JW's approved CD19 CAR-T therapy to target solid tumors.

  • Aim to advance a first-in-class "mark and kill" strategy using oncolytic virus-induced CD19 expression to make solid tumors targetable by CD19 CAR-T cells.

  • Seek to generate impactful preclinical and clinical data to inform further development of combination immunotherapies.

Partner introductions and roles

  • The presenting team includes experienced executives and clinicians with backgrounds in major biotech firms and over 18 FDA-approved drugs.

  • Imugene provides the oncolytic virus and leads preclinical work; JW supplies the CAR-T product and sponsors the phase I trial in China.

  • One partner provides the oncolytic virus (CF33-CD19/onCARlytics) platform.

  • The other partner contributes the CD19 CAR-T cell therapy (Carteyva®) and commercial CAR-T infrastructure.

  • Both companies bring expertise in immuno-oncology and cell therapy development.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Imugene earnings date

Logotype for Imugene Limited
Q1 202611 Dec, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Imugene earnings date

Logotype for Imugene Limited
Q1 202611 Dec, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Imugene Limited is an Australian biotechnology company focused on developing immunotherapies for the treatment of cancer. The company’s research is centered around activating the immune system to target and eliminate cancer cells, utilizing a range of technologies, including oncolytic viruses and B-cell activating immunotherapies. Imugene’s clinical pipeline includes treatments for various cancer types, and the company works on advancing its therapies through preclinical and clinical development stages. The company is headquartered in Sydney, Australia, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage